We have observed
16 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after January 16, 2014).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Transposition-mediated identification of specific binding or functional proteins
SYSTEM AND METHOD FOR ANNOTATING IMAGES
AQUEOUS FORMULATION COMPRISING AT LEAST A NEUTRAL SALT AND A BIOPHARMACEUTICAL PROTEIN
HYGIENIC OR PERSONAL CARE ARTICLE HAVING A CONTENT OF COPPER OR COPPER IONS
METHODS AND COMPOSITIONS FOR TREATING NEPHROGENIC DIABETES INSIPIDUS
Method of producing an immunoligand/payload conjugate by means of a sequence-specific transpeptidase enzyme
DETACHMENT MECHANISM FOR A CENTRAL VENOUS ACCESS FILTER AND METHOD OF USE
Multi-component dressing for wound treatment on the human or animal body with application of reduced pressure
WOUND CARE DEVICE FOR TREATING WOUNDS BY MEANS OF SUBATMOSPHERIC PRESSURE
SET COMPRISING WOUND DRESSING AND WOUND FILLER
NON-IONIC, LOW OSMOLAR CONTRAST AGENTS FOR DELIVERY OF ANTISENSE OLIGONUCLEOTIDES AND TREATMENT OF DISEASE
MODULAR PROSTHETIC ABUTMENT SYSTEM
TOPOGRAPHICAL FEATURES AND PATTERNS ON A SURFACE OF A MEDICAL DEVICE AND METHODS OF MAKING THE SAME
PREDICTION OF CANCER TREATMENT BASED ON DETERMINATION OF ENZYMES OR METABOLITES OF THE KYNURENINE PATHWAY
IMMUNOTHERAPY FOR THE TREATMENT OF CANCER
RADICAL POLYMERIZATION METHOD AND POLYMERIZATION REACTION APPARATUS